Huntington's disease (HD) is caused by a CAG repeat expansion that encodes a polyglutamine (polyQ) expansion in the HD disease protein, huntingtin (HTT). PolyQ expansion promotes misfolding and aggregation of mutant HTT (mHTT) within neurons. The cellular pathways, including ubiquitin-dependent processes, by which mHTT is regulated remain incompletely understood. Ube2W is the only ubiquitin conjugating enzyme (E2) known to ubiquitinate substrates at their amino (N)-termini, likely favoring substrates with disordered N-termini. By virtue of its N-terminal polyQ domain, HTT has an intrinsically disordered amino terminus. In studies employing immortalized cells, primary neurons and a knock-in (KI) mouse model of HD, we tested the effect of Ube2W deficiency on mHTT levels, aggregation and neurotoxicity. In cultured cells, deficiency of Ube2W activity markedly decreases mHTT aggregate formation and increases the level of soluble monomers, while reducing mHTT-induced cytotoxicity. Consistent with this result, the absence of Ube2W in HdhQ200 KI mice significantly increases levels of soluble monomeric mHTT while reducing insoluble oligomeric species. This study sheds light on the potential function of the non-canonical ubiquitin-conjugating enzyme, Ube2W, in this polyQ neurodegenerative disease.
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A B S T R A C T
Huntington's disease (HD) is caused by a CAG repeat expansion that encodes a polyglutamine (polyQ) expansion in the HD disease protein, huntingtin (HTT). PolyQ expansion promotes misfolding and aggregation of mutant HTT (mHTT) within neurons. The cellular pathways, including ubiquitin-dependent processes, by which mHTT is regulated remain incompletely understood. Ube2W is the only ubiquitin conjugating enzyme (E2) known to ubiquitinate substrates at their amino (N)-termini, likely favoring substrates with disordered N-termini. By virtue of its N-terminal polyQ domain, HTT has an intrinsically disordered amino terminus. In studies employing immortalized cells, primary neurons and a knock-in (KI) mouse model of HD, we tested the effect of Ube2W deficiency on mHTT levels, aggregation and neurotoxicity. In cultured cells, deficiency of Ube2W activity markedly decreases mHTT aggregate formation and increases the level of soluble monomers, while reducing mHTT-induced cytotoxicity. Consistent with this result, the absence of Ube2W in HdhQ200 KI mice significantly increases levels of soluble monomeric mHTT while reducing insoluble oligomeric species. This study sheds light on the potential function of the non-canonical ubiquitin-conjugating enzyme, Ube2W, in this polyQ neurodegenerative disease.
Introduction
The accumulation of ubiquitinated proteins is a pathological hallmark shared by many neurodegenerative diseases including Huntington's disease (HD). HD is the most common among nine polyglutamine (polyQ) diseases, caused by CAG repeat expansions that encode a polyQ stretch in the disease proteins. In HD, when the polyQ length exceeds a threshold close to 40 glutamines, the HD protein huntingtin (HTT) becomes pathogenic (Zoghbi and Orr, 2000) . HD patients typically develop involuntary movements such as chorea and dystonia, neuropsychiatric symptoms and cognitive deficits. Pathologically, HD displays preferential degeneration of the striatum, with the medium spiny neurons expressing dopamine D2 receptors, DARPP-32 and encephalin being particularly vulnerable (Augood et al., 1996; Ginovart et al., 1997; Sapp et al., 1995; Crook and Housman, 2012) .
In HTT, the N-terminal 17 amino acids and adjacent polyQ stretch are largely unstructured and disordered, contributing to the relative "disorderedness" of this domain of the protein (Baias et al., 2017) . Mutant HTT (mHTT) becomes insoluble and forms aggregates known as inclusion bodies in neuronal nuclei, perinuclear regions and neurites (DiFiglia, 1997; Davies et al., 1997; Gutekunst et al., 1999) . These inclusion bodies contain N-terminal fragments of HTT, ubiquitin, proteasomal components and numerous other proteins (Davies et al., 1997) . The presence of ubiquitin and proteasomal subunits in HD inclusions supports the importance of ubiquitin-dependent pathways in HD. However, the precise roles of ubiquitination pathways in HD are not fully understood. Studies have shown that numerous components of ubiquitin-dependent systems can contribute to and alter HTT degradation, aggregation and cytotoxicity (Todi and Paulson, 2011; Popovic et al., 2014; Schipper-Krom et al., 2012 
